High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study (Q70333172)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 April 1984
edit
Language Label Description Also known as
English
High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study
scientific article published on 01 April 1984

    Statements

    High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit